March 12, 2021

Children Aged 5 Put On Antidepressants In The UK

Antidepressants are being prescribed to children as young as five in the UK.
March 5, 2021

Expert Group In Norway To Assess Deaths Reported Following Coronavirus Vaccination

The Norwegian Medicines Agency has set up an expert group to review 102 deaths amongst frail elderly people following vaccination against coronavirus.
January 19, 2021

Common Antibiotics May Trigger Mental Breakdowns

Evidence suggests doxycycline and other common antibiotics can raise the risk of psychiatric problems, hallucinations, and suicidal thoughts.
January 19, 2021

Americans Making Vaccine Injury Claims Could Face Bureaucratic ‘Black Hole’

Lost in their country’s launch of the coronavirus vaccine is a fact that few Americans realize when they roll up their sleeves. In cases of serious illness from the shots, the injured are blocked from suing and are steered instead to an obscure federal bureaucracy with a record of seldom paying claims.
December 10, 2020

UK Drugs Regulator Forced To Defend Fast Pace Of Pfizer Gene-Based Vaccine Approval

Britain's medicines regulator continues to insist its approval of the Pfizer-BioNTech coronavirus vaccine met all safety standards, after officials in Europe and the United States queried the rapid process.
December 10, 2020

Antiviral Drugs Have No Effect On Mortality In COVID-19

For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have little to no effect on mortality, according to a study published online in the New England Journal of Medicine.
December 3, 2020

Declarations Of Pharma Funding Are Still Not Transparent

Details have been released of money spent last year by drug companies on UK healthcare organizations and doctors.
November 26, 2020

Multibillionaire Warren Buffett Makes Big Investment In US Pharmaceutical Firms

Berkshire Hathaway, the investment company run by multibillionaire Warren Buffet, bought shares in drug companies AbbVie, Bristol-Myers Squibb, Merck and Pfizer between July and September, according to filings with the US regulator.